The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3 , Pages 615-619 , March 2008

Mediastinoscopy might not be necessary in patients with non–small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3

  • Benjamin Enoch Lee, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of California at Davis, Sacramento, Calif
    • ,
  • Jonathon Redwine, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of California at Davis, Sacramento, Calif
    • ,
  • Cameron Foster, MD

      Affiliations

    • Department of Radiology, Division of Nuclear Medicine, University of California at Davis, Sacramento, Calif
    • ,
  • Elma Abella, MD

      Affiliations

    • Northern California PET Imaging Center, Sacramento, Calif
    • ,
  • Teri Lown, RN, OCN

      Affiliations

    • University of California at Davis, Cancer Center, Sacramento, Calif
    • ,
  • Derick Lau, MD, PhD

      Affiliations

    • Department of Internal Medicine, Division of Oncology, University of California at Davis, Sacramento, Calif
    • ,
  • David Follette, MD

      Affiliations

    • Division of Cardiothoracic Surgery, University of California at Davis, Sacramento, Calif
    • Corresponding Author InformationAddress for reprints: David Follette, MD, Division of Cardiothoracic Surgery, University of California at Davis, UC Davis Cancer Center, 4501 X Street, Sacramento, CA 95817

Received 26 June 2007 ,Revised 27 August 2007 ,Accepted 14 September 2007.

References 

  1. Jemal A, Siegal R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2007;56:106–130
  2. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–2507
  3. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg. 2004;78:1017–1023
  4. Halpern BS, Schiepers C, Weber WA, Crawford TL, Fueger BJ, Phelps ME, et al. Presurgical staging on non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest. 2005;128:2289–2297
  5. Roberts PF, Follette DM, Von Haag DW, Park JA, Valk PE, Pounds TR, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg. 2000;70:1154–1160
  6. Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer. 2005;47:235–242
  7. Lee BE, Von Haag DW, Lown T, Lau D, Calhoun R, Follette D. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;133:746–752
  8. Gonzalez-Stawinski GV, Lemaire A, Merchant F, O'Halloran E, Coleman RE, Harpole DH, et al. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1900–1904
  9. Lemaire A, Nikolic I, Petersen T, Haney JC, Toloza EM, Harpole DH, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006;82:1185–1189
  10. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence and survival. J Thorac Cardiovasc Surg. 2005;130:151–159
  11. Vesselle H, Turcotte E, Wiens L, Schmidt R, Takasugi JE, Lalani T, et al. Relationship between non-small cell lung cancer fluorodeoxyglucose uptake at positron emission tomography and surgical stage with relevance to patient prognosis. Clin Cancer Res. 2004;10:4709–4716
  12. Bryant AS, Cerfolio RJ, Klemm KM, Ojha B. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Ann Thorac Surg. 2006;82:417–422
  13. Nabi HA, Zubeldia JM. Clinical applications of F18-FDG in oncology. J Nucl Med Technol. 2002;30:3–9
  14. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  15. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  16. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest. 2007;131:539–548
  17. Annema JT, Versteegh MI, Veselic M, Welker L, Mauad T, Sont JK, et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005;294:931–936
  18. Rusch VW. Mediastinoscopy: an endangered species?. J Clin Oncol. 2005;23:8283–8285
  19. Grunenwald DH, Albain KS. The potential role of surgery after induction treatment. Semin Radiat Oncol. 2004;14:335–339
  20. Cerfolio RJ, Bryant AS. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with non-small cell lung cancer. Ann Thorac Surg. 2007;83:1826–1830
  21. Chung JH, Lee WW, Park SY, Choe G, Sung SW, Chung JK, et al. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Eur J Surg Oncol. 2006;32:989–995

 Read at the Thirty-third Annual Meeting of the Western Thoracic Surgical Association, Santa Ana Pueblo, NM, June 27–30, 2007.

PII: S0022-5223(07)01607-8

doi: 10.1016/j.jtcvs.2007.09.029

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3 , Pages 615-619 , March 2008

Article Tools

* Image Usage & Resolution